Skip to main content
Premium Trial:

Request an Annual Quote

OncoMethylome Hopes to Raise $11.3M in Private Placement of New Shares

NEW YORK (GenomeWeb News) — OncoMethylome Sciences hopes to raise around €8 million ($11.3 million) or more after issuing a private offering of new shares to institutional and qualified investors, the company said today.
 
However, the Belgian gene methylation-testing shop said it will not sell more than 10 percent of its outstanding shares.
 
OncoMethylome said it plans to use the funds to pursue clinical trials for its cancer diagnostics and tests for targeted cancer treatments.

The Scan

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.

New Insights Into TP53-Driven Cancer

Researchers examine in Nature how TP53 mutations arise and spark tumor development.

Mapping Single-Cell Genomic, Transcriptomic Landscapes of Colorectal Cancer

In Genome Medicine, researchers present a map of single-cell genomic and transcriptomic landscapes of primary and metastatic colorectal cancer.

Expanded Genetic Testing Uncovers Hereditary Cancer Risk in Significant Subset of Cancer Patients

In Genome Medicine, researchers found pathogenic or likely pathogenic hereditary cancer risk variants in close to 17 percent of the 17,523 patients profiled with expanded germline genetic testing.